ClinPharm Consulting Launches Population Pharmacokinetics Service
Posted in the Apex Forum
Since: Jul 10
#1 Nov 3, 2010
(Research Triangle Park, N.C.) ClinPharm Consulting, a specialized consulting firm offering a unique paradigm for empowering drug development pipelines, has added Giulia Ghibellini, Ph.D. to its team of credentialed industry veterans to implement a new population pharmacokinetics service.
Population PK modeling is an integral part of drug development and is typically conducted within or across large studies (e.g., Phase 2 and 3) to explain variability by identifying factors that may influence the pharmacokinetic behavior of an investigational drug.
For more information on ClinPharm Consulting services, email [email protected] om or visit www.clinpharmconsulting.com .
ClinPharm Consulting is a specialized consulting firm offering a unique paradigm for empowering drug development pipelines. Our business model focuses on matching scientific and pharmacokinetic/pharmacodynami c expertise with superior writing capabilities to maximize the impact of individual studies on an overall clinical pharmacology program. We specialize in helping small biopharmaceutical companies with minimal R&D infrastructure find scalable solutions for emerging early phase drug development challenges, providing an unmatched combination of technical expertise and robust understanding of clinical pharmacology from a scientific, regulatory and clinical conduct perspective.
The breadth of our experience allows ClinPharm Consulting to be a complete resource for clients to set up their drug development programs for success. ClinPharm Consulting typically engages clients as early as the IND planning stage to develop robust clinical pharmacology strategies and then works as a horizontally integrated, in-house resource to assist with the execution and analysis of those strategies. Our efforts not only include the design, conduct, and analysis of clinical pharmacology studies but also helping clients transition from nonclinical research into early phase clinical trials as well as transitioning from healthy volunteers into patients with the target disease.
Add your comments below
|snitches in durham nc. (Dec '11)||Jul 11||Mike||6|
|The Thread: The 6.25.17 Issue||Jul 8||Shirvell s Shrivel||6|
|Together, Triangle Transit Agencies Seek Federa...||Jul 2||Macmcf||1|
|Beware Mike Luchansky (Aug '10)||Jun 30||Guilty Guilty Guilty||73|
|Sarah boring aka Sarah morgan...aka sarah the s...||Jun 24||Cuz I can||1|
|sarah boring||Apr '17||u dont wanna know me||3|
|sue||Mar '17||cuz i fookin can||2|
Find what you want!
Search Apex Forum Now
Copyright © 2017 Topix LLC